Back to Search
Start Over
Half-Dose Anticoagulation for Venous Thromboembolism and Phlegmasia Cerulea Dolens in a Patient With Recurrent Subdural Hematoma.
- Source :
-
Cureus [Cureus] 2021 Sep 17; Vol. 13 (9), pp. e18048. Date of Electronic Publication: 2021 Sep 17 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Anticoagulation for venous thromboembolism (VTE) in patients with recurrent subdural hematoma (SDH) is challenging. It becomes even more challenging when the patient develops phlegmasia cerulea dolens (PCD). We present a 66-year-old female with a recent history of recurrent SDH who received half-dose heparin therapy for VTE and PCD. The patient had improvement of dyspnea and resolution of PCD after two days of treatment. She was discharged with half-dose enoxaparin. At her one-month follow-up, there was no evidence of new SDH or progression of VTE. Half-dose anticoagulation therapy should be considered in patients with recurrent SDH when anticoagulation is inevitable.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright © 2021, Hu et al.)
Details
- Language :
- English
- ISSN :
- 2168-8184
- Volume :
- 13
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Cureus
- Publication Type :
- Report
- Accession number :
- 34692280
- Full Text :
- https://doi.org/10.7759/cureus.18048